WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed…
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June…
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in…
BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- On September 19, at the HUAWEI Innovative Product Launch event in Barcelona, Spain,…
Join us for an enlightening and transformative experience at the Changing Face of Addiction Virtual Summit, where we bring together…
NEW YORK, Sept. 19, 2024 /PRNewswire/ -- Report with market evolution powered by AI- The global elderly and disabled assistive…
CHICAGO, Sept. 19, 2024 /PRNewswire/ -- Anju, a leading provider of adaptive life sciences software solutions, is pleased to announce its…
NEW YORK, Sept. 19, 2024 /PRNewswire/ -- The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly's…
WASHINGTON, Sept. 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for…
Life Science Innovators Partner to Transform the Samples-to-Insight Cycle SAN DIEGO, Sept. 19, 2024 /PRNewswire/ -- CS Genetics, an innovative genomics…